This Solicitation opportunity from Department Of Veterans Affairs was posted on February 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6505--Ustekinumab Pens/Syringes or Biosimilar

Closed

36E79726R0006Federal

Submission Closed02/10/2026, 08:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

Federal

Pharmaceutical Product SupplyThis subcontract for the Department of Veterans Affairs National CMOP Office involves the supply of pharmaceutical products to prime contractors. The agreement mandates that all products feature distinct 11-digit NDCs and maintain expiration dates of more than 12 months from the date of delivery. To maintain quality control, shipments are limited to a maximum of three lot numbers and must include 100cc bottles with child safety caps and unit-of-use packaging. The supplier is required to provide OEM documentation and strictly adhere to regulations regarding Counterfeit Items and Gray Market products. All deliveries must be accompanied by appropriate packing slips. Performance for this contract takes place in Ladson, South Carolina, under NAICS code 325412.

National Cmop Office (36C770)

POSTED

DEADLINE

6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312)

Solicitation # 36C77027Q0013

The Department of Veterans Affairs National CMOP Office is conducting market research through a Sources Sought notice to identify qualified sources for Calcium 500mg/Vitamin D 500unit chewable tablets in 90-count packaging. This effort is for market research purposes only and does not constitute a solicitation or an obligation to issue a contract. Interested vendors must submit their company point of contact, SAM Unique Entity ID, and a capability statement via email to the contract specialist by October 29, 2026. The anticipated requirement involves a total quantity of 3,200 packages, delivered in monthly increments of 800 units over four months, with the first delivery due 10 days after receipt of order. Products must be sourced directly from the Original Equipment Manufacturer and possess an FDA therapeutic equivalence code of A, unless all drugs in the family group are B rated. Technical requirements include a distinct eleven-digit National Drug Code for each product, a minimum shelf life of 12 months from delivery, and specific bottle dimensions of at least 100cc with a 5.75-inch circumference and child-safety caps for packages under 500 count. Strict packaging and labeling standards apply, requiring bar codes that conform to GS1-128 or HIBCC/HIBC standards with a minimum ANSI/ISO/IEC Quality Grade C. Bar codes must be placed on both the outside wrapper and the immediate container. Shipping documentation must include the VA Purchase Order and Obligation numbers, and products must be sorted by lot number, with only one lot per box. Invoicing will be handled by the VA Fiscal Service Center, and the invoice price must strictly match the purchase order price to avoid payment delays.

National Cmop Office (36C770)

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine HCl and Epinephrine pharmaceutical anesthetic combinations for prime contractors supporting Department of Defense medical supply contracts. The requirement specifies 1.8 mL cartridges containing 0.500 PCT W/V Bupivacaine HCl and 0.005 mg Epinephrine/mL, packaged in sets of 50. The total delivery quantity is 1.000 CN of injection cartridges, which must adhere to NSN 6505-01-189-3973 and all applicable FDA manufacturing standards. Managed by the Medical Supply Chain Pharm FSA, the contract mandates a minimum shelf life of 15 months upon delivery. The performance location is designated as FPO 96675. Interested parties must respond by November 2, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dibucaine Ointment USP Formulation and ManufacturingThis subcontract involves the chemical formulation and manufacturing of Dibucaine Ointment USP for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The scope of work requires blending USP-grade Dibucaine and ointment base to a 1% concentration in accordance with USP standards. To ensure a 36-month shelf life, the provider must maintain strict quality control and temperature-controlled storage between 15 and 30 degrees Celsius for the bulk delivery of the product. Compliance requirements for this contract include mandatory FDA registration and adherence to the Buy American Act and the Berry Amendment. The performance of these services is centered in Fort Stewart, Georgia, under NAICS code 325412. Interested parties must respond by November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Pressure Sensitive Adhesive Tape (NSN 7510-01-679-4381)This subcontract involves the supply of pressure sensitive adhesive tape, identified by NSN 7510-01-679-4381, to prime contractors supporting Department of Defense supply contracts. The vendor is required to deliver a physical quantity of 2,000 rolls of tape that strictly adhere to the DLA Master List of Technical and Quality Requirements, specifically requirement RA001, and all other specifications associated with the provided National Stock Number. The contract is managed under NAICS code 325412 for the agency Construction and Equipment T & IFO EQ. Performance of the contract will take place in Cherry Point, zip code 28533-8051. The solicitation was posted on October 25, 2026, with a response deadline set for November 5, 2026.

CONSTRUCTION & EQUIPMENT T & IFO EQ

POSTED

DEADLINE

Malaria Detection Test Kit SupplierThis subcontract involves the supply of malaria detection test kits for prime contractors supporting Defense Logistics Agency medical supply contracts. The scope of work requires the manufacture or sourcing of kits featuring a malaria sporozoite antigen panel assay, which must be packaged in sturdy white plastic boxes containing canister tubes and vials. All delivered products under NSN 6550-01-551-5327 must strictly adhere to shelf-life requirement RS016 Type I Code M, ensuring a non-extendable 24-month period. Managed by the Department of Defense under the Medical Supply Chain MD Surg FSF, the contract is categorized under NAICS code 325412. Performance for this requirement is centered at Fort Campbell, Kentucky. Interested parties should note the response deadline of November 2, 2026, to provide the necessary medical supplies.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medroxyprogesterone Acetate Tablets SupplyThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Medroxyprogesterone Acetate Tablets, USP, 2.5 MG in 100 count bottles. The selected provider is responsible for the manufacture or wholesale of the pharmaceutical compound, ensuring all products are delivered in commercial packaging with markings that adhere to Medical Marking Standard No. 1. The contract specifically covers National Stock Number 6505-01-276-2029 for delivery to Fort Campbell. Strict adherence to quality and regulatory standards is required, including compliance with USP standards, the Buy American Act, and the Berry Amendment. This opportunity falls under NAICS code 325412 and is intended for prime contractors supporting DLA medical supply contracts. The response deadline for this requirement is November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Zolmitriptan Tablet Supply (2.5 MG)This subcontract involves the manufacture and procurement of Zolmitriptan 2.5 MG rapidly disintegrating tablets to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The contractor is responsible for delivering 3,000 packages of NSN 6505-01-523-0353, with each package consisting of individually sealed blister packs containing 6 units. All products must strictly adhere to FDA GMP standards and AHFS Classification Number 28:92. The project falls under NAICS code 325412 and specifies Fort Campbell as the place of performance. Interested parties must note the response deadline of November 2, 2026, following the posting date of October 25, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Activated Suspension Charcoal SupplyThis subcontract with the Department of Defense Medical Supply Chain Pharm FSA requires the production or procurement of 2,000 bottles of medical-grade Activated Suspension Charcoal, identified by NSN 65050128880. The contractor must ensure all materials meet strict NSN specifications, including the use of temperature-controlled storage maintained between 20 and 25 degrees Celsius. Packaging must adhere to RP001 and Medical Marking Standard No. 1 using sealed unit containers. The agreement mandates full compliance with the Buy American Act and requires reporting through the Wide Area Workflow system. Performance will take place at Fort Campbell, Kentucky, under NAICS code 325412. The response deadline for this solicitation is November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Levonorgestrel and Ethinyl Estradiol TabletsThis subcontract, issued by the Department of Defense Medical Supply Chain Pharm FSA, involves the procurement of Levonorgestrel and Ethinyl Estradiol tablets to support prime contractors delivering DLA supply contracts. The selected provider is responsible for the manufacture or procurement of the pharmaceutical compound, ensuring that all packaging and labeling strictly adhere to the 29 CFR 1910.1200 Hazard Communication Standard and the DLA Master List of Technical and Quality Requirements RA001. The scope of work requires the delivery of 1,000 packages of the pharmaceutical tablets to Fort Campbell. Eligible bidders must maintain an active SAM registration to be considered for this opportunity. The contract falls under NAICS code 325412, with a response deadline set for November 2, 2026. All deliverables must meet the specific technical and quality standards mandated by the agency to ensure pharmaceutical compliance and safety.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sodium Chloride Injection (0.9%) SupplierThis subcontract involves the supply of 0.9% Sodium Chloride Injection for prime contractors under Department of Defense supply contracts managed by the Medical Supply Chain Pharm FSA. The requirement specifies medical-grade saline in 100 ML volumes utilizing 150 ML fill plastic containers, delivered in packages of 64 units under NSN 6505-01-330-8924. Performance will take place in Fort Campbell, Kentucky. The supplier must adhere to strict regulatory and technical standards, including packaging per MIL-STD-2073-1E and MPWM000001 and labeling according to Medical Marking Standard No. 1A. Additionally, the contract mandates full compliance with the Buy American Act and the Berry Amendment. The solicitation is categorized under NAICS code 325412, with a response deadline of November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Norgestimate and Ethinyl Estradiol TabletsThis subcontract involves the procurement or manufacture of FDA-regulated Norgestimate and Ethinyl Estradiol tablets, identified by NSN 6505-01-666-3685, to support prime contractors delivering for the Department of Defense Medical Supply Chain Pharm FSA. The selected provider must hold valid FDA authorization for the distribution or manufacture of these pharmaceuticals and maintain compliance with NIST SP 800-171 standards. The contract requires strict adherence to packaging and marking guidelines, including MIL-STD-129, Medical Marking Standard No. 1, and ASTM D3951, with palletization following RP001. The final deliverable consists of one package to be delivered to Fort Bragg, North Carolina. The solicitation was posted on October 25, 2026, with a response deadline of November 2, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 7 days

AI Contract Overview

The Department of Veterans Affairs (VA) National Acquisition Center plans to issue Request for Proposal (RFP) number 36E79726R0006 for the procurement of Ustekinumab pens/syringes or FDA-approved biosimilar products. This unrestricted solicitation encompasses supply for multiple federal healthcare entities, including the VA (covering Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to one responsible offeror capable of providing a reliable and uninterrupted source of supply for the specified items. The award will be for a one-year base period with four pre-priced option years, totaling a potential five years of contract performance. Distribution of awarded products is required exclusively through the VA's and DoD's Pharmaceutical Prime Vendor Programs. The solicitation includes three primary product line items differentiated by strength and packaging formats (syringe and vial), with estimated annual requirements ranging from approximately 2,900 to 45,700 units depending on the dosage form. Offerors must provide the exact drug name as it appears on the label, carry a unique National Drug Code (NDC) exclusive to their product, and must not relabel or overlay any existing manufacturer labeling. If both syringe and vial forms exist commercially for a given strength, offerors are required to offer both at the same price with no price differentiation allowed. Biosimilar products must be FDA-licensed under the Public Health Service Act (42 U.S.C. § 262), must meet all statutory biosimilarity criteria, and be listed in the FDA’s Purple Book as comparable to the innovator product. The procurement follows commercial item acquisition procedures under FAR Part 12 with the solicitation to be issued electronically via SAM.gov around January 12, 2026, and proposal submissions closing by January 27, 2026. No paper copies or telephone requests for solicitation documents will be entertained, emphasizing electronic access and submission. Christopher Carthron is the designated Contract Specialist and sole point of contact for all procurement communications. Specific details on pricing, evaluation criteria, and inspection/acceptance locations are not provided in the pre-solicitation notice, although standard FDA regulatory compliance and labeling requirements form key performance and quality standards.